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With more and more treatments becoming available for
people with rare diseases, we encounter the issue of age-
ing more often. A number of patients with rare, chronic
diseases have experienced a number of remarkable tran-
sitions in their lives. The most important transition is
the one from no treatment at all to treatment becoming
available, like in haemophilia about 45 years ago.
Another transition is the one that during their lives they
go from one disease to a number of diseases (co-mor-
bidity) through the natural process of getting older or as
a consequence of the side-effects of treatment.
These transitions can cause a number of problems.
The first problem could be the lack of co-ordination
between medical specialists and paramedical staff. The
second is polypharmacy - the use of multiple medica-
tions and as a consequence of these first two problems
a third problem occurs which I prefer to address as the
‘fear’ factor.
The ‘fear’ factor can be described as a lack of control
when you are not able to influence or check the treat-
ment you receive.
When more and more older persons with rare,
chronic diseases will gradually transit to special care
institutions for the elderly, more knowledge should be
available in these institutions to deal with these new
groups of patients. In this way, these patients will differ
a lot from the group of elderly persons who develop co-
morbidity at a much older age.
Some of these issues will be addressed in this presen-
tation, based on the personal experience of the speaker,
who is also the (co-)author of several recent books on
getting older with chronic diseases, like haemophilia and
HIV.
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